Stocks TelegraphStocks Telegraph
Screener NEW

SGMT Stock Price History and Quote Analysis Insights for Investors

NASDAQ : SGMT

Sagimet Biosciences Inc.

$4.39
-0.15-3.30%
At Close 4:00 PM
63.14
BESG ScoreESG Rating
Loading...

Stock Price Today

Sagimet Biosciences Inc. (SGMT) stock declined over -3.30%, trading at $4.39 on NASDAQ, down from the previous close of $4.54. The stock opened at $4.52, fluctuating between $4.36 and $4.54 in the recent session.

Stock Snapshot

4.54
Prev. Close
4.52
Open
134.66M
Market Cap
30.67M
Number of Shares
4.3557
Day Low
4.54
Day High
-11.26
P/E Ratio
66.53%
Free Float in %
-0.39
EPS (TTM)
N/A
Book Value
N/A
Cash Flow per Share
396.97K
Volume

Stock Price History Chart

DateOpenHighLowCloseVolume
Dec 13, 20244.524.544.364.39396.98K
Dec 12, 20244.704.774.524.54293.14K
Dec 11, 20244.945.064.664.71234.65K
Dec 10, 20245.055.204.734.89432.34K
Dec 09, 20245.115.204.965.04557.44K
Dec 06, 20245.175.244.855.10748.4K
Dec 05, 20245.215.264.664.66673.3K
Dec 04, 20245.285.505.175.26682.67K
Dec 03, 20245.335.495.185.31666.53K
Dec 02, 20245.605.715.345.36440.03K
Nov 29, 20245.605.795.465.69205.23K
Nov 27, 20245.205.655.195.54531.43K
Nov 26, 20244.965.224.835.17298.09K
Nov 25, 20244.905.114.874.93373.52K
Nov 22, 20244.454.774.354.76407.24K
Nov 21, 20244.464.764.274.50501.25K
Nov 20, 20244.414.554.274.52259.22K
Nov 19, 20244.254.604.194.41505.02K
Nov 18, 20244.734.854.364.36584.1K
Nov 15, 20245.055.184.584.73837.49K

Contact Details

San Mateo, CA 94402

United States

Website: https://sagimet.comContact: 650 561 8600

About Company

Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional lipid metabolism pathways. Its lead drug candidate is Denifanstat, a FASN inhibitor for the treatment of nonalcoholic steatohepatitis and acne. The company is also developing TVB-3567, a FASN inhibitor for the treatment of various types of cancers. The company was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. Sagimet Biosciences Inc. was incorporated in 2006 and is headquartered in San Mateo, California.

Company Information

Employees8
Beta0
Sales or RevenueN/A
5Y Sales Change%0%
Fiscal Year EndsN/A
SectorHealthcare
IndustryBiotechnology

Frequently Asked Questions

What is the current Sagimet Biosciences Inc. (SGMT) stock price?

Sagimet Biosciences Inc. (NASDAQ: SGMT) stock price is $4.39 in the last trading session. During the trading session, SGMT stock reached the peak price of $4.54 while $4.36 was the lowest point it dropped to. The percentage change in SGMT stock occurred in the recent session was -3.3% while the dollar amount for the price change in SGMT stock was -$0.15.

SGMT's industry and sector of operation?

The NASDAQ listed SGMT is part of Biotechnology industry that operates in the broader Healthcare sector. Sagimet Biosciences Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of SGMT?

No Data

How SGMT did perform over past 52-week?

SGMT's closing price is 83.68% higher than its 52-week low of $2.39 where as its distance from 52-week high of $20.71 is -78.8%.

How many employees does SGMT have?

Number of SGMT employees currently stands at 8.

Link for SGMT official website?

Official Website of SGMT is: https://sagimet.com

How do I contact SGMT?

SGMT could be contacted at phone 650 561 8600 and can also be accessed through its website. SGMT operates from 155 Bovet Road, San Mateo, CA 94402, United States.

How many shares of SGMT are traded daily?

SGMT stock volume for the day was 396.97K shares. The average number of SGMT shares traded daily for last 3 months was 1.49M.

What is the market cap of SGMT currently?

The market value of SGMT currently stands at $134.66M with its latest stock price at $4.39 and 30.67M of its shares outstanding.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph